Login

Financial Snapshot

Revenue
TTM
$4506B
Gross Margin
TTM
65.09%
Net Income
TTM
$191.8B
Current Assets
2026 Q1
$3091B
Current Liabilities
2026 Q1
$2430B
Current Ratio
2026 Q1
127.21%
Total Assets
2026 Q1
$15450B
Total Liabilities
2026 Q1
$7680B
Book Value
2026 Q1
7774B
Cash
2026 Q1
$595.1B
P/E
TTM
40.35
Free Cash Flow
TTM
$630.5B

Stock Price

Loading...
Market Cap: $7.7376 Trillion

About Takeda Pharmaceutical Co Ltd

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 47,455 full-time employees. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and inflammatory diseases, neuroscience, and oncology, and also focuses on plasma-derived therapies.

Industry: Pharmaceutical Preparations

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support